Literature DB >> 16178966

Pathogenesis of Helicobacter pylori Infection.

Céu Figueiredo1, José Carlos Machado, Yoshio Yamaoka.   

Abstract

As with many infectious diseases, only a fraction of people infected with Helicobacter pylori develop clinical disease, and host genetics, host immune response, and bacterial virulence factors appear to play critical roles. There has been considerable interest in putative bacterial virulence factors and, while several have been identified, it is not clear whether they act independently or in concert. Disease associations have been proposed for the cag pathogenicity island (PAI), vacA, and genes encoding outer membrane proteins (OMPs). Numerous studies published in the last year have provided new insights into the function of these putative virulence factors in gastroduodenal pathogenesis. This article will review the recent novel findings (from April 2004) for the roles of the putative disease-associated virulence factors as well as their interaction with host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178966     DOI: 10.1111/j.1523-5378.2005.00339.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  19 in total

1.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

2.  Involvement of vesicle-associated membrane protein 7 in human gastric epithelial cell vacuolation induced by Helicobacter pylori-produced VacA.

Authors:  Hirosato Mashima; Junko Suzuki; Toshiya Hirayama; Yukako Yoshikumi; Hideki Ohno; Hirohide Ohnishi; Hiroshi Yasuda; Toshiro Fujita; Masao Omata
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

Review 3.  Effect of Helicobacter pylori on gastric epithelial cells.

Authors:  Shatha Alzahrani; Taslima T Lina; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world.

Authors:  Christine Chung; Asalia Olivares; Eugenia Torres; Ozlem Yilmaz; Henry Cohen; Guillermo Perez-Perez
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

5.  mRNA levels of TLR4 and TLR5 are independent of H pylori.

Authors:  Elvira Garza-González; Virgilio Bocanegra-García; Francisco-Javier Bosques-Padilla; Juan-Pablo Flores-Gutiérrez; Francisco Moreno; Guillermo-Ignacio Perez-Perez
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

6.  DC-LAMP+ dendritic cells are recruited to gastric lymphoid follicles in Helicobacter pylori-infected individuals.

Authors:  Malin Hansson; Malin Sundquist; Susanne Hering; B Samuel Lundin; Michael Hermansson; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

7.  CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells.

Authors:  Malin Hansson; Michael Hermansson; Helena Svensson; Anders Elfvin; Lars-Erik Hansson; Erik Johnsson; Asa Sjöling; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates.

Authors:  Lino E Torres; Karelia Melián; Arlenis Moreno; Jordis Alonso; Carlos A Sabatier; Mayrín Hernández; Ludisleydis Bermúdez; Boris L Rodríguez
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

9.  Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.

Authors:  Mehmet Cindoruk; Ilhan Yetkin; Serpil Muge Deger; Tarkan Karakan; Erdal Kan; Selahattin Unal
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  Helicobacter pylori infection in Ontario: prevalence and risk factors.

Authors:  Farah Naja; Nancy Kreiger; Terrence Sullivan
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.